Tuija Lundan
Turku, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group.
Journal: Annals of hematology
Published: December 17, 2018
Acute Lymphoblastic Leukemia With INPP5D-ABL1 Fusion Responds to Imatinib Treatment.
Journal: Journal of pediatric hematology/oncology
Published: July 26, 2018
A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma.
Journal: Bone marrow transplantation
Published: June 17, 2015
The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.
Journal: Haematologica
Published: October 05, 2014
Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma.
Journal: Blood cancer journal
Published: August 24, 2014
Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia.
Journal: Leukemia
Published: February 28, 2014
Imatinib and pegylated IFN-α2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response.
Journal: European journal of haematology
Published: December 18, 2013
Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients.
Journal: British journal of haematology
Published: December 05, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026